Mrv0541 02231218152 d 16 16 0 0 1 0 999 V2000型1.6500 -2.2193 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 1.9058 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 0.2558 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.7935 0.6683 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 3.7935 1.4933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 0.6683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -0.5693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 0.2558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 1.4933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -0.9818 0.0000 C0 0 0 0 0 0 0 0 0 3.7935 -0.9818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 2.7308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 1.4933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -1.8068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -1.8068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -2.2193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 14 1 0 0 0 0 2 5 1 0 0 0 0 2 12 1 0 0 0 0 2 13 1 4 0 0 0 0 3 1 6 0 0 0 0 3 1 6 0 0 0 3 7 1 0 0 0 0 4 1 5 0 0 0 0 4 8 1 6 0 0 0 6 9 1 0 0 0 0 7 10 2 0 0 0 0 7 11 1 0 0 0 0 10 14 1 0 0 0 0 11 15 20 0 0 0 14 16 2 0 0 0 0 15 16 1 0 0 0 0 M END >
DB06204 >
drugbank >
CC [C@H] ([C@@H] (C) CN (C) C) C1 = CC (O) = CC = C1 >
InChI = 1 s / C14H23NO c1-5-14 (11 (2) 10 - 15 (3) 4) 12-7-6-8-13 (16) 9 - 12 / h6-9、11、14、16 h, 5、10 h2, 1-4H3 / t11 - 14 + / mo / s1 >
KWTWDQCKEHXFFR-SMDDNHRTSA-N >
C14H23NO >
221.3385 >
221.177964363 >
2 >
39 >
0.9967421718105077 >
26.584596110174548 >
1 >
1 >
0 >
1 >
3 - ((2 r, 3 r) 1 -(二甲胺基)2-methylpentan-3-yl]苯酚>
3.47 >
2.9585336273557528 >
-2.45 >
0 >
1 >
1 >
1 >
10.27711538224564 >
9.604633592123502 >
23.47 >
69.5588 >
5 >
1 >
7.80e-01 g/l >
生物素>
1 >
DB06204 >
批准>
Tapentadol >
Tapentadol >
Apo-tapentadol;Nucynta;Nucynta CR;Nucynta呃;Nucynta延长释放;纽辛塔:是的
Palexia;TAPAL >
盐酸他他多$$$$